300
Participants
Start Date
March 1, 2024
Primary Completion Date
March 1, 2029
Study Completion Date
March 1, 2029
Observational
There is no clinical intervention as part of this study. Participants will receive treatment as per their clinical treating team.
Lead Sponsor
Kirby Institute
OTHER_GOV